Lower serum CXCL9 in patients with hypersensitivity pneumonitis (HP) is associated with a more significant decline in vital capacity, suggesting that CXCL9 is a crucial predictor of lung function deterioration similar to IPF [187]. Here, CXCL9 is linked to hypersensitivity pneumonitis.